Accelerate Diagnostics Schedules Call to Review Second Quarter 2017 Results for August 3rd
July 18, 2017 17:38 ET
|
Accelerate Diagnostics, Inc.
TUCSON, Ariz., July 18, 2017 (GLOBE NEWSWIRE) -- Accelerate Diagnostics, Inc. announced today it will host a conference call on Thursday, August 3, 2017 to discuss its second quarter 2017 financial...
Accelerate Diagnostics to Present at the 37th Annual Growth Stock Conference hosted by William Blair & Company
June 07, 2017 18:06 ET
|
Accelerate Diagnostics, Inc.
TUCSON, Ariz., June 07, 2017 (GLOBE NEWSWIRE) -- Lawrence Mehren, president and chief executive officer of Accelerate Diagnostics, will present at the 37th Annual Growth Stock Conference hosted by...
Accelerate Diagnostics Announces Closing of $79.3 Million Upsized Offering
May 15, 2017 17:14 ET
|
Accelerate Diagnostics, Inc.
TUCSON, Ariz., May 15, 2017 (GLOBE NEWSWIRE) -- Accelerate Diagnostics, Inc. (Nasdaq:AXDX) announced the closing of its previously announced underwritten public offering of 2,750,000 shares of its...
Accelerate Diagnostics Reports 191 Instruments Under Contract and 3x Revenue Growth for First Quarter 2017
May 03, 2017 16:05 ET
|
Accelerate Diagnostics, Inc.
TUCSON, Ariz., May 03, 2017 (GLOBE NEWSWIRE) -- Accelerate Diagnostics, Inc. today announced preliminary financial results for the quarter ending March 31, 2017 including signed customer evaluation...
Accelerate Diagnostics Schedules Call to Review First Quarter 2017 Results for May 3rd
April 18, 2017 17:53 ET
|
Accelerate Diagnostics, Inc.
TUCSON, Ariz., April 18, 2017 (GLOBE NEWSWIRE) -- Accelerate Diagnostics, Inc. announced today it will host a conference call on Wednesday, May 3rd, 2017 to discuss its first quarter 2017 financial...
Accelerate Diagnostics Receives FDA Marketing Authorization for the Accelerate Pheno™ System and Accelerate PhenoTest™ BC Kit
February 23, 2017 21:45 ET
|
Accelerate Diagnostics, Inc.
TUCSON, Ariz., Feb. 23, 2017 (GLOBE NEWSWIRE) -- Accelerate Diagnostics, Inc. (Accelerate) today announced that the U.S. Food and Drug Administration has granted the de novo request to market the...
Great Basin Scientific Participates in CDC’s Get Smart About Antibiotics Week, Releases Antimicrobial Stewardship Survey Findings
November 17, 2016 09:00 ET
|
Great Basin Scientific, Inc.
Survey finds hospitals moving toward antimicrobial stewardship programs; Company’s Staph ID/R Blood Culture Panel provides fast and affordable diagnostic tool in fight against antibiotic...
Great Basin Scientific Completes Clinical Trial for Stool Bacterial Pathogens Panel
November 08, 2016 07:00 ET
|
Great Basin Scientific, Inc.
SALT LAKE CITY, Nov. 08, 2016 (GLOBE NEWSWIRE) -- Great Basin Scientific, Inc. (OTCQB:GBSN), a molecular diagnostics company, announced today the successful completion of the clinical trial of its...
Accelerate Diagnostics to Report Third-Quarter 2016 Results on November 9th
October 21, 2016 17:45 ET
|
Accelerate Diagnostics, Inc.
TUCSON, Ariz., Oct. 21, 2016 (GLOBE NEWSWIRE) -- Accelerate Diagnostics, Inc. announced today it will report third-quarter 2016 financial results on Wednesday, November 9, 2016. President and...